Association of antioxidized low-density lipoprotein antibodies with vascular arterial events and renal manifestations in systemic lupus erythematosus patients: Comment on the article by Frostegård et al [6]

Arthritis and Rheumatism

Volumn 54, Issue 6, 2006, Pages 2035-2036

  Bertoli, Ana M ^a   Fernández, Monica ^a   McGwin Jr , Gerald ^a   Vilá, Luis M ^b   Reveille, John D ^c   Alarcón, Graciela S ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b UNIVERSITY OF PUERTO RICO MEDICAL SCIENCES CAMPUS   (Puerto Rico)

^c UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OXIDIZED LOW DENSITY LIPOPROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN ANTIBODY; UNCLASSIFIED DRUG;

CLINICAL FEATURE; HEMOLYSIS; HEMOLYTIC ANEMIA; KIDNEY DISEASE; LETTER; NEPHRITIS; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTOPENIA; VASCULAR DISEASE;

ANEMIA, HEMOLYTIC; ANTIBODIES; HUMANS; LIPOPROTEINS, LDL; LUPUS ERYTHEMATOSUS, SYSTEMIC; NEPHRITIS; OXIDATION-REDUCTION; THROMBOCYTOPENIA;

EID: 33745037667     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.21760     Document Type: Letter

References (5)

1. Frostegard J, Svenungsson E, Wu R, Gunnarsson I, Lundberg IE, Klareskog L, et al. Lipid peroxidation is enhanced in patients with systemic lupus erythematosus and is associated with arterial and renal disease manifestations. Arthritis Rheum 2005;52:192-200.
2. Koskenmies S, Vaarala O, Widen E, Kere J, Palosuo T, Julkunen H. The association of antibodies to cardiolipin, β2-glycoprotein I, prothrombin, and oxidized low-density lipoprotein with thrombosis in 292 patients with familial and sporadic systemic lupus erythematosus. Scand J Rheumatol 2004;33:246-52.
3. Hayem G, Nicaise-Roland P, Palazzo E, de Bandt M, Tubach F, Weber M, et al. Anti-oxidized low-density-lipoprotein (OxLDL) antibodies in systemic lupus erythematosus with and without antiphospholipid syndrome. Lupus 2001;10:346-51.
4. Toloza SM, Uribe AG, McGwin G Jr, Alarcon GS, Fessler BJ, Bastian HM, et al. Systemic lupus erythematosus in a multiethnic US cohort (LUMINA). XXIII. Baseline predictors of vascular events. Arthritis Rheum 2004;50:3947-57.
5. Romero FI, Amengual O, Atsumi T, Khamashta MA, Tinahones FJ, Hughes GR. Arterial disease in lupus and secondary antiphospholipid syndrome: association with anti-β2-glycoprotein I antibodies but not with antibodies against oxidized low-density lipoprotein. Br J Rheumatol 1998;37:883-8.